| Literature DB >> 25050277 |
Ritesh Kumar Srivastav1, Hefazat Hussain Siddiqui2, Tarique Mahmood1, Farogh Ahsan1.
Abstract
OBJECTIVE: The study was conducted to evaluate cardioprotective effect of silk cocoon (Abresham) Bombyx mori (B. mori) on isoprenaline-induced myocardial infarction. This study deals with the cocoons, which is called Abresham in the Unani system of medicine. It is one of the 64 drugs which Avicenna has mentioned in Avicenna's tract on cardiac drugs and used in the treatment of cardiovascular diseases. Abresham is a chief ingredient of the two very famous Unani formulation viz. Khamira Abresham Sada, and Khamira Abresham Hakim Arshad Wala.Entities:
Keywords: Abresham; Bombyx mori; Cardioprotective Effect; Isoprenaline
Year: 2013 PMID: 25050277 PMCID: PMC4075710
Source DB: PubMed Journal: Avicenna J Phytomed ISSN: 2228-7930
Observation table for grading of heart
|
|
|
|---|---|
|
| Grade 0 |
|
| Grade 4 |
|
| Grade 1 |
|
| Grade 3 |
|
| Grade 2 |
Body weight, heart weight, heart/body weight ratio
|
|
|
|
|
|---|---|---|---|
|
| 208 | 0.81 | 3.8 |
|
| 191 | 1.08 | 5.6 |
|
| 216 | 0.88 | 4.0 |
|
| 220 | 1.01 | 4.5 |
|
| 225 | 0.98 | 4.3 |
Effect of ethanolic extract of B. mori on CK–MB, LDH, AST, and ALT levels in rats by isoprenaline-induced cardiac toxicity
|
|
|
|
|
|
|---|---|---|---|---|
|
| 155.137±24.5 | 103.630±2.41 | 107.780±2.11 | 1.034±0.020 |
|
| 285.911±24.9 | 255.144±16.9 | 307.743±22.44 | 1.260±0.044 |
|
| 161.277±23.4 | 105.226±22.8 | 111.106±4.27 | 1.068±0.029 |
|
| 199.65± 18.10 | 214.25± 3.63 | 247.72± 7.22 | 1.26± 0.04 |
|
| 171.85±21.63 | 140.60± 16.50 | 238.96± 16.33 | 1.15± 0.03 |
Values are mean±SEM for five animals in each group.
AST: Aspartate amino transferaces; ALT: Alanine transaminase; LDH: Lactate dehydrogenase CK-MB: Creatine kinase; NC: Normal control; ISO: isoprenaline; STD: Standard; TG1: Test group 1; TG2: Test group 2.
p<0.001 When ISO group is compared with NC group;
p<0.001 When standard group is compared with ISO group;
p<0.01 When experimental group is compared with ISO group;
p<0.001 When experimental group is compared with ISO group
Release of troponin–I in various treatment groups
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| -ve | +ve | -ve | +ve | -ve |
|
| -ve | +ve | -ve | +ve | -ve |
|
| -ve | +ve | +ve | -ve | +ve |
|
| -ve | +ve | -ve | +ve | -ve |
|
| -ve | +ve | +ve | -ve | +ve |
+ve: Presence of troponin in serum; -ve: Absence of troponin in serum.
Figure 1Visual photographs of dissected rat heart: a- (NC) group showing no scar, oedema, or capillary dilation; b- (ISO) group showing hypertrophy, oedema, and change in colour (circle and arrow); c- (STD) group showing no oedema, capillary dilation but showing inflammation and redness (circle); d- (TG1) group showing redness, inflammation near ventricle (circle); e- (TG2) group showing no redness, but shows minor inflammation (arrow).